307 related articles for article (PubMed ID: 2609705)
1. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Hengels KJ; Strohmeyer G
Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
[TBL] [Abstract][Full Text] [Related]
2. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
Samloff IM
Gastroenterology; 1982 Jan; 82(1):26-33. PubMed ID: 7053333
[TBL] [Abstract][Full Text] [Related]
3. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
Samloff IM; Liebman WM; Panitch NM
Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
[TBL] [Abstract][Full Text] [Related]
4. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1975 Dec; 69(6):1196-200. PubMed ID: 1193320
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of human pepsinogen A and pepsinogen C.
Biemond I; Jansen JB; Crobach LF; Kreuning J; Lamers CB
J Clin Chem Clin Biochem; 1989 Jan; 27(1):19-25. PubMed ID: 2723588
[TBL] [Abstract][Full Text] [Related]
6. [Group I pepsinogen (PG I) in the serum and urine after total gastrectomy].
Kodama M; Takahashi T; Kida K; Yamaguchi T
Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):686-93. PubMed ID: 6493192
[TBL] [Abstract][Full Text] [Related]
7. Serum group I pepsinogen levels and their relation to gastric acid secretion in patients with and without recurrent ulcer.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1976 Mar; 70(3):309-13. PubMed ID: 1248696
[TBL] [Abstract][Full Text] [Related]
8. Pepsinogens, pepsins, and peptic ulcer.
Samloff IM; Taggart RT
Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic usefulness of serum group I pepsinogen determination.
Peyre S; Di Napoli A; Pelissero A; Sategna-Guidetti C
Gastroenterol Clin Biol; 1983 Oct; 7(10):793-8. PubMed ID: 6628912
[TBL] [Abstract][Full Text] [Related]
10. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay].
Matsumoto K; Hashimoto K; Samori T; Taniguchi M; Kotera K; Nishi S; Takatsuji M; Higashi K; Itoh K
Rinsho Byori; 1992 Sep; 40(9):977-81. PubMed ID: 1434035
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
14. Effect of betazole on serum group I pepsinogen levels: relationship to gastric acid output in unoperated and postoperative patients.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1977 May; 72(5 Pt 1):845-8. PubMed ID: 849814
[TBL] [Abstract][Full Text] [Related]
15. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
16. Pepsinogen polymorphism in human gastric mucosa in relation to gastric diseases.
Kucerová Z; Korbová L; Kohout J; Pesková M; Sváb J
Sb Lek; 1993; 94(2):163-8. PubMed ID: 7992009
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of serum pepsinogen and progastricsin in man.
Axelsson CK
Scand J Clin Lab Invest Suppl; 1992; 210():81-96. PubMed ID: 1455183
[TBL] [Abstract][Full Text] [Related]
18. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
19. Localization of pepsinogen (A and C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa.
Waalewijn RA; Meuwissen SG; Pals G; Hoefsmit EC
Eur J Cell Biol; 1991 Feb; 54(1):55-60. PubMed ID: 2032552
[TBL] [Abstract][Full Text] [Related]
20. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
